iRGD peptide

SKU: orb1296711

Description

The iRGD peptide (c(CRGDKGPDC)) is a cyclic 9-mer originally discovered through in vivo phage display in tumor models. It functions as a tumor-penetrating peptide, enhancing the delivery of co-administered therapeutics in both in vitro and in vivo cancer research.

Research Area

Signal Transduction

Key Properties

• Target: Integrin
• CAS Number: 1392278-76-0
• MW: 948.04
• Purity: 98.77% (May vary between batches)
• Formula: C₃₅H₅₇N₁₃O₁₄S₂
• SMILES: O=C1[C@]2(N(CCC2)C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CSSC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)N1)[H]

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Integrin, Inhibitor, iRGD peptide, inhibit, c(CRGDKGPDC)

Compound Identifiers

PubChem CID

134611625